Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus
- PMID: 104180
- DOI: 10.1007/BF00576365
Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus
Abstract
The susceptibility of 21 strains of Aspergillus (11 of A. fumigatus, 8 of A, niger, and 2 of A. flavus) isolated from human pathologic specimens to Amphotericin B and Miconazole has been comparatively studied. Determination of the minimal inhibitory concentration of both drugs in a liquid medium showed a noticeably variability for the different strains. The values obtained for Amphotericin B varied between 0.25 microgram/ml (2 strains) and 1.25 microgram/ml (5 strains) after 48 hours, and between 1,25 microgram/ml (1 strain) and 50 microgram/ml (1 strain) after 10 days. For Miconazole the results varied between 0.1 microgram/ml (1 strain) and 25 microgram/ml (1 strain) after 48 hours of incubation, and between 0.5 microgram/ml (5 strains) and greater than 100 microgram/ml after 10 days. The variability of these results indicates the usefulness of carrying our in vitro sensitivity studies whenever it is possible.
Similar articles
-
In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.Chemotherapy. 1978;24(6):364-7. doi: 10.1159/000237809. Chemotherapy. 1978. PMID: 699677
-
Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.Mycopathologia. 1994 Dec;128(3):129-33. doi: 10.1007/BF01138472. Mycopathologia. 1994. PMID: 7739726
-
MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.Antimicrob Agents Chemother. 1988 May;32(5):780-1. doi: 10.1128/AAC.32.5.780. Antimicrob Agents Chemother. 1988. PMID: 3134851 Free PMC article.
-
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.Diagn Microbiol Infect Dis. 2001 Dec;41(4):211-4. doi: 10.1016/s0732-8893(01)00295-4. Diagn Microbiol Infect Dis. 2001. PMID: 11777662
-
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.Int J Antimicrob Agents. 2007 Jan;29(1):108-11. doi: 10.1016/j.ijantimicag.2006.09.019. Int J Antimicrob Agents. 2007. PMID: 17189101
Cited by
-
Minimal inhibitory concentrations of lucknomycin, a new polyenic derivative, for Candida and Aspergillus spp.Antimicrob Agents Chemother. 1983 Jul;24(1):132-3. doi: 10.1128/AAC.24.1.132. Antimicrob Agents Chemother. 1983. PMID: 6625552 Free PMC article.
-
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.Br J Clin Pharmacol. 2003 Dec;56 Suppl 1(Suppl 1):10-6. doi: 10.1046/j.1365-2125.2003.01993.x. Br J Clin Pharmacol. 2003. PMID: 14616408 Free PMC article. Clinical Trial.
-
Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method.J Clin Microbiol. 1984 Jan;19(1):54-6. doi: 10.1128/jcm.19.1.54-56.1984. J Clin Microbiol. 1984. PMID: 6418762 Free PMC article.
-
Rapid and highly reproducible method for antifungal susceptibility testing of Aspergillus species.J Clin Microbiol. 1993 Apr;31(4):1009-12. doi: 10.1128/jcm.31.4.1009-1012.1993. J Clin Microbiol. 1993. PMID: 8463380 Free PMC article.